Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bobby Gaspar
CEO | Chief Executive Officer | 60 | 01/15/01 |
Frank Thomas
PSD | President | 54 | 01/18/01 |
Leslie Meltzer
CTO | Chief Tech/Sci/R&D Officer | - | 01/18/01 |
Nicoletta Loggia
CTO | Chief Tech/Sci/R&D Officer | - | 09/21/09 |
Fulvio Mavilio
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Renee T. Leck
IRC | Investor Relations Contact | - | - |
Christopher York
SEC | Corporate Secretary | - | - |
Braden Parker
PRN | Corporate Officer/Principal | - | - |
John Cerio
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Abdul Mullick
BRD | Director/Board Member | - | 24/01 |
Yasuo Fujii
BRD | Director/Board Member | - | 24/01 |
60 | - | ||
Director/Board Member | 62 | 24/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 126,572,749 | 81,786,701 ( 64.62 %) | 0 | 64.62 % |
Company contact information
Orchard Therapeutics Plc
245 Hammersmith Road 3rd Floor
W6 8PW, London
+44 20 3 808 8286
http://www.orchard-tx.comSector
1st Jan change | Capi. | |
---|---|---|
+31.52% | 690B | |
+24.88% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+14.17% | 235B | |
+5.41% | 199B | |
-9.94% | 195B | |
+3.98% | 161B |